76 related articles for article (PubMed ID: 1966410)
1. In vivo and in vitro models of demyelinating disease: a phosphoprotein phosphatase in host cell endosomes dephosphorylating the nucleocapsid protein of coronavirus JHM.
Mohandas DV; Dales S
Adv Exp Med Biol; 1990; 276():255-60. PubMed ID: 1966410
[TBL] [Abstract][Full Text] [Related]
2. Endosomal association of a protein phosphatase with high dephosphorylating activity against a coronavirus nucleocapsid protein.
Mohandas DV; Dales S
FEBS Lett; 1991 May; 282(2):419-24. PubMed ID: 1674698
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro models of demyelinating disease. Possible relationship between induction of regulatory subunit from cAMP dependent protein kinases and inhibition of JHMV replication in cultured oligodendrocytes.
Wilson GA; Mohandas DV; Dales S
Adv Exp Med Biol; 1990; 276():261-6. PubMed ID: 1966411
[TBL] [Abstract][Full Text] [Related]
4. Characterization of coronavirus JHM variants isolated from Wistar Furth rats with a viral-induced demyelinating disease.
Morris VL; Tieszer C; Mackinnon J; Percy D
Virology; 1989 Mar; 169(1):127-36. PubMed ID: 2538027
[TBL] [Abstract][Full Text] [Related]
5. Dephosphorylation of the nucleocapsid protein of inoculum JHMV may be essential for initiating replication.
Kalicharran K; Dales S
Adv Exp Med Biol; 1995; 380():485-9. PubMed ID: 8830528
[No Abstract] [Full Text] [Related]
6. Regulation of the initiation of coronavirus JHM infection in primary oligodendrocytes and L-2 fibroblasts.
Kalicharran K; Mohandas D; Wilson G; Dales S
Virology; 1996 Nov; 225(1):33-43. PubMed ID: 8918531
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro models of demyelinating disease: activation of the adenylate cyclase system influences JHM virus expression in explanted rat oligodendrocytes.
Beushausen S; Narindrasorasak S; Sanwal BD; Dales S
J Virol; 1987 Dec; 61(12):3795-803. PubMed ID: 2824815
[TBL] [Abstract][Full Text] [Related]
8. Infection by coronavirus JHM of rat neurons and oligodendrocyte-type-2 astrocyte lineage cells during distinct developmental stages.
Pasick JM; Dales S
J Virol; 1991 Sep; 65(9):5013-28. PubMed ID: 1651420
[TBL] [Abstract][Full Text] [Related]
9. Coronavirus JHM induced demyelinating disease: specific domains on the E2-protein are associated with neurovirulence.
Wege H; Winter J; Massa P; Dörries R; ter Meulen V
Adv Exp Med Biol; 1987; 218():307-20. PubMed ID: 2449042
[TBL] [Abstract][Full Text] [Related]
10. MHV leader RNA secondary structure affects binding to the nucleocapsid protein.
Welter LM; Stohlman SA; Deans RJ
Adv Exp Med Biol; 1990; 276():247-54. PubMed ID: 1966409
[No Abstract] [Full Text] [Related]
11. Structure and function studies of the nucleocapsid protein of mouse hepatitis virus.
Masters PS; Parker MM; Ricard CS; Duchala C; Frana MF; Holmes KV; Sturman LS
Adv Exp Med Biol; 1990; 276():239-46. PubMed ID: 1966408
[No Abstract] [Full Text] [Related]
12. In vivo and in vitro transcription of small mRNAs containing a leader sequence from mouse hepatitis virus strain JHM.
Hayashi M; Mizutani T; Ishida K; Maeda A; Watanabe T; Namioka S
Adv Exp Med Biol; 1995; 380():537-9. PubMed ID: 8830537
[No Abstract] [Full Text] [Related]
13. In vivo and in vitro models of demyelinating diseases--VIII: Genetic, immunologic and cellular influences on JHM virus infection of rats.
Sorensen O; Beushausen S; Puchalski S; Cheley S; Anderson R; Coulter-Mackie M; Dales S
Adv Exp Med Biol; 1984; 173():279-98. PubMed ID: 6331119
[No Abstract] [Full Text] [Related]
14. Distribution and trafficking of JHM coronavirus structural proteins and virions in primary neurons and the OBL-21 neuronal cell line.
Pasick JM; Kalicharran K; Dales S
J Virol; 1994 May; 68(5):2915-28. PubMed ID: 8151762
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro models of demyelinating disease. IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases.
Sorensen O; Coulter-Mackie MB; Puchalski S; Dales S
Virology; 1984 Sep; 137(2):347-57. PubMed ID: 6091333
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of the mouse hepatitis virus nucleocapsid protein.
Wilbur SM; Nelson GW; Lai MM; McMillan M; Stohlman SA
Biochem Biophys Res Commun; 1986 Nov; 141(1):7-12. PubMed ID: 3026381
[TBL] [Abstract][Full Text] [Related]
17. Murine hepatitis virus JHM variants isolated from Wistar Furth rats with viral-induced neurological disease.
Morris VL; Wilson GA; McKenzie CE; Tieszer C; La Monica N; Banner L; Percy D; Lai MM; Dales S
Adv Exp Med Biol; 1990; 276():411-6. PubMed ID: 1966431
[No Abstract] [Full Text] [Related]
18. The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: definition of critical epitopes by variant analysis.
Wege H; Winter J; Meyermann R
J Gen Virol; 1988 Jan; 69 ( Pt 1)():87-98. PubMed ID: 2447229
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro models of demyelinating diseases. XII. Persistence and expression of corona JHM virus functions in RN2-2 Schwannoma cells during latency.
Coulter-Mackie M; Adler R; Wilson G; Dales S
Virus Res; 1985 Oct; 3(3):245-61. PubMed ID: 3000100
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro models of demyelinating disease: JHM virus in the rat central nervous system localized by in situ cDNA hybridization and immunofluorescent microscopy.
Sorensen O; Dales S
J Virol; 1985 Nov; 56(2):434-8. PubMed ID: 2997466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
